Enerpac Tool Group Earnings Call Transcripts
Fiscal Year 2026
-
Second quarter fiscal 2026 delivered 2% organic revenue growth, with strong product sales offset by service declines, especially in EMEA. Guidance was narrowed, innovation accelerated, and a major UK contract was secured, while restructuring and capital returns continued.
-
Shareholders elected eight directors, approved the auditor for fiscal 2026, and supported executive compensation. Quorum was achieved with over 95% of shares represented, and no questions were raised during the meeting.
-
Q1 fiscal 2026 saw solid product sales growth and strong order rates, offset by service revenue declines in EMEA. Guidance for the year is maintained, with margin improvement expected in the second half and continued investment in innovation and M&A opportunities.
Fiscal Year 2025
-
Record revenue and strong EBITDA margin achieved despite industrial sector headwinds. APAC and Americas drove growth, while EMEA lagged due to macro weakness. Fiscal 2026 guidance anticipates continued outperformance, with robust capital allocation and ongoing investment in innovation and M&A.
-
Record Q3 revenue with 6% year-over-year growth, strong performance in Americas and Cortland Biomedical, and robust order backlog for DTA. Margins pressured by service mix and tariffs, but pricing actions and restructuring support profitability. Guidance maintained, with cautious outlook amid economic uncertainty.
-
Organic sales grew 5% year-over-year, with strong performance in HLT and robust growth in Americas and APAC. EBITDA margins declined due to mix, but guidance and cash flow targets are maintained, supported by a strong balance sheet and ongoing innovation.
-
Revenue grew 2.3% year-over-year, with strength in EMEA and Asia-Pacific offsetting weakness in the Americas. Gross margin declined due to mix, but adjusted EPS rose 3%. Integration of DTA is progressing well, and the company remains optimistic for improved performance as macro conditions stabilize.
Fiscal Year 2024
-
Fiscal 2024 saw modest organic growth, margin expansion, and strong free cash flow, despite a soft industrial market. The DTA acquisition broadens capabilities and geographic reach, while 2025 guidance anticipates continued margin strength and disciplined capital allocation.
-
Margin expansion and operational efficiency gains drove improved profitability despite a soft industrial market. EMEA delivered strong double-digit growth, while APAC faced headwinds. Innovation, e-commerce, and disciplined capital allocation supported positive outlook.